Yahoo
    Shanghai - Delayed Quote CNY

    Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)

    34.70 -0.69 (-1.95%)
    At close: October 30 at 3:00:01 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 688091.SS
    • Previous Close 35.39
    • Open 35.12
    • Bid 34.68 x --
    • Ask 34.70 x --
    • Day's Range 34.65 - 36.35
    • 52 Week Range 33.80 - 66.20
    • Volume 1,614,164
    • Avg. Volume 3,056,012
    • Market Cap (intraday) 7.173B
    • Beta (5Y Monthly) -0.44
    • PE Ratio (TTM) 102.06
    • EPS (TTM) 0.34
    • Earnings Date --
    • Forward Dividend & Yield -- (0.00%)
    • Ex-Dividend Date May 17, 2024
    • 1y Target Est --

    Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development of anti-tumor drugs and related products in China. The company offers paclitaxel polymer micelles for injection for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, and gynecological tumors. Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China.

    www.yizhongpharma.com

    457

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Shanghai Yizhong Pharmaceutical Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    688091.SS
    26.17%
    SSE Composite Index (000001.SS)
    9.32%

    1-Year Return

    688091.SS
    36.60%
    SSE Composite Index (000001.SS)
    9.73%

    3-Year Return

    688091.SS
    10.78%
    SSE Composite Index (000001.SS)
    19.11%

    5-Year Return

    688091.SS
    53.64%
    SSE Composite Index (000001.SS)
    1.46%

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      21.41%

    • Return on Assets (ttm)

      1.65%

    • Return on Equity (ttm)

      4.69%

    • Revenue (ttm)

      321.61M

    • Net Income Avi to Common (ttm)

      68.86M

    • Diluted EPS (ttm)

      0.34

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      936.46M

    • Total Debt/Equity (mrq)

      1.68%

    • Levered Free Cash Flow (ttm)

      -59.22M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    688131.SS Shanghai Haoyuan Chemexpress Co., Ltd.
    92.09 +10.79%
    002773.SZ Chengdu Kanghong Pharmaceutical Group Co., Ltd
    18.80 -0.53%
    300558.SZ Betta Pharmaceuticals Co., Ltd.
    40.10 +0.15%
    603590.SS Beijing Konruns Pharmaceutical Co.,Ltd.
    24.81 -6.52%
    300723.SZ ApicHope Pharmaceutical Group Co., Ltd.
    27.66 -2.33%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: